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2-Oxoglutarate dehydrogenase (Ogdh) is an important mitochondria redox sensor that can undergo
S-glutathionylation following an increase in H2O2 levels. Although S-glutathionylation is required to
protect Ogdh from irreversible oxidation while simultaneously modulating its activity it remains un-
known if glutathione can also modulate reactive oxygen species (ROS) production by the complex. We
report that reduced (GSH) and oxidized (GSSG) glutathione control ∙−O2 /H2O2 formation by Ogdh through
protein S-glutathionylation reactions. GSSG (1 mM) induced a modest decrease in Ogdh activity which
was associated with a signiﬁcant decrease in ∙−O2 /H2O2 formation. GSH had the opposite effect, amplifying
∙−O2 /H2O2 formation by Ogdh. Incubation of puriﬁed Ogdh in 2.5 mM GSH led to signiﬁcant increase
in ∙−O2 /H2O2 formation which also lowered NADH production. Inclusion of enzymatically active glutar-
edoxin-2 (Grx2) in reaction mixtures reversed the GSH-mediated ampliﬁcation of ∙−O2 /H2O2 formation.
Similarly pre-incubation of permeabilized liver mitochondria from mouse depleted of GSH showed an
approximately 3.5-fold increase in Ogdh-mediated ∙−O2 /H2O2 production that was matched by a sig-
niﬁcant decrease in NADH formation which could be reversed by Grx2. Taken together, our results de-
monstrate GSH and GSSG modulate ROS production by Ogdh through S-glutathionylation of different
subunits. This is also the ﬁrst demonstration that GSH can work in the opposite direction in mi-
tochondria-amplifying ROS formation instead of quenching it. We propose that this regulatory me-
chanism is required to modulate ROS emission from Ogdh in response to variations in glutathione redox
buffering capacity.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
It is appreciated more than ever that controlled low grade ROS
formation is required to modulate cell functions in tandem with
other signaling cascades [1]. Mitochondria are quantiﬁably the
most important source of ROS using it as a superimposed co-signal
to ﬁne tune the timing of cellular signaling pathways [1,2]. It is
imperative that ROS formation is maintained under strict control
since higher than normal production can irreversibly damage cell
constituents. ROS levels are maintained by a suite of antioxidant
systems dedicated to quenching different oxyradicals generated as
a consequence of electron movement in mitochondria [3]. Mi-
tochondrial ROS genesis starts when a small fraction of electrons
liberated during nutrient oxidation prematurely exit theB.V. This is an open access article
e; ROS, reactive oxygen spe-
SOD, superoxide dehy-
Newfoundland, Canada A1B
.respiratory chain to univalently reduce O2 generating the proximal
mitochondrial ROS superoxide ( ∙−O2 ) (Fig. 1a) [3,4]. Superoxide is
then rapidly dismutated by superoxide dismutase (SOD) yielding
hydrogen peroxide (H2O2) [4]. Following its production, H2O2 has
multiple fates; it is either quenched by redox buffering networks
or utilized in signaling [5]. The former is composed of two key
systems; the glutathione (GSH) system and thioredoxin system [6].
The GSH system is composed of two enzymes glutathione perox-
idase (Gpx) and glutathione reductase (GR). For H2O2 quenching,
Gpx reacts with 2 molecules of GSH in tandem with H2O2 to yield
glutathione disulﬁde (GSSG) which is rapidly reduced back to GSH
by GR in the presence of NADPH. Notably, GSH is highly con-
centrated in mitochondria (1–5 mM) relative to GSSG (0.1 mM)
which also imbues it with capacity to serve as a major redox buffer
[7].
Redox signaling has emerged as an important means for con-
trolling mitochondrial bioenergetics [8,9]. Signaling is mediated
through the modiﬁcation of redox switches, protein cysteine thiols
that sense local changes in the mitochondrial redox buffering
environment [10]. Mitochondria contain a number of these
switches which are found in Krebs cycle enzymes, respiratoryunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Oxidative metabolism and ROS production by 2-oxoglutarate (Ogdh). (A) Schematic illustration of the oxidation of carbon and oxidative phosphorylation in mi-
tochondria. Electrons liberated from the oxidation of nutrients in the Krebs cycle are ferried through the respiratory chain the terminal electron acceptor di-oxygen (O2).
Electron movement is coupled to the formation of a membrane potential composed of electrochemical difference in protons which drives ATP production. Also depicted are
the sites of ROS formation (red stars) in the nutrient oxidation and respiratory chain. Note that the red star in the Krebs cycle represents ROS formation by Ogdh and Pdh,
respectively. Sites for ROS production in the electron transport chain include sn-glycero-3-phosphate dehydrogenase (G3pdh), Complexes I, II, and III. For simplicity, other
ROS forming sites including electron-transferring ﬂavoprotein-ubiquinone oxidoreductase (Etfqo), proline dehydrogenase (Prodh), dihydrolipoamide dehydrogenase
(Dhodh), 2-oxoadipate dehydrogenase (Dhtkd1), and sulﬁde-quinone oxidoreductase (Sqo), were omitted. The reader is encouraged to consult these articles on the 12 sites
of production in mitochondria [3,20,34,35]. (B) Generation of ∙−O2 /H2O2 by 2-oxoglutarate dehydrogenase Ogdh complex. The complex is composed of E1 (2-oxoglutarate
decarboxylase), E2 (dihydrolipoamide succinyl transferase), and E3 (dihydrolipoamide dehydrogenase) which couple 2-oxoglutarate oxidation to NADH formation. The
enzyme complex contains multiple copies of each subunit indicated by a green outline. 2-Oxoglutarate is ﬁrst oxidized by E1 resulting in the liberation of CO2 and the
succinylation of thiamine pyrophosphate (TPP). The succinyl moiety is then transferred to a vicinal thiol on lipoamide in the E2 subunit which then interacts with CoASH to
yield succinyl-CoA and dihydrolipoamide. The dihydrolipoamide is re-oxidized by the E3 subunit where the liberated electrons are transferred through FAD to reduce NADþ
forming NADH. Note that Ogdh contains two ROS generating sites depicted by red stars and can also be S-glutathionylated on all three subunits. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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fusion, protein import, or induction of mitoptosis [9,11,12]. These
redox switches also serve as an important means of modulating
mitochondrial ROS formation where changes in mitochondrial
redox buffering networks feedback to inhibit ROS formation at
sites of production [10]. Although cysteines can undergo a range of
redox modiﬁcations, mitochondria are a 'hot-bed‘' for S-glu-
tathionylation reactions which involves the formation of a dis-
ulﬁde bridge between cysteine and glutathione [13]. Mitochondria
contain a number of S-glutathionylation targets which includes
enzymes and respiratory complexes that generate ROS [8]. These
reactions are highly speciﬁc and enzymatically mediated. Speciﬁ-
city is conferred by the presence of S-glutathioylation motifs,
characterized by solvent accessible cysteine residues surrounded
by positively charged amino acids. S-glutathionylation reactions
are catalyzed by glutaredoxins (Grx), thiol oxidoreductases that
harbor glutathionylase and deglutathionylase activities [14]. Grx2,
which is found in the matrix of mitochondria, catalyzes the re-
versible S-glutathionylation of Complex I in response to changes inGSH/GSSG which modulates ROS production [15,16]. Grx2-medi-
ated S-glutathionylation reactions also modulate uncoupling pro-
tein-3 mediated control over mitochondrial ROS formation [17].
Ogdh sits at a major metabolic hub in the Krebs cycle linking
carbon ﬂux to the biosynthesis and degradation of amino acids.
The catalytic activity of Ogdh depends on three subunits, 2-ox-
oglutarate decarboxylase (E1), dihydrolipoamide succinyltransfer-
ase (E2), and dihydrolipoamide dehydrogenase (E3) which work in
tandem to transfer electrons from 2-oxoglutarate at the E1 subunit
reducing NADþ to NADH at the E3 subunit (Fig. 1b). The NADH
generated is utilized to drive the oxidative phosphorylation of ADP
producing ATP. Ogdh also serves as a mitochondrial redox sensor
and is modulated by changes in ROS. The vicinal thiols on dihy-
drolipoamide in the E2 subunit are especially sensitive to oxidation
by H2O2 which decreases Ogdh activity in response to increased
mitochondrial ROS [18]. Following oxidation by H2O2, S-glu-
tathionylation is required to protect vicinal thiols on lipoic acid in
the E2 subunit from further oxidation [19]. Importantly S-glu-
tathionylation of Ogdh is reversible where removal of GSH fully
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Ogdh also produces ROS and has recently been shown to be a
major source of ∙−O2 /H2O2 [20]. Ogdh can produce
∙−O2 /H2O2 when
metabolizing 2-oxoglutarate and NADþ or in the presence of μM
amounts of NADH [20,21]. The E3 subunit of Ogdh has been
characterized as the chief site for ∙−O2 /H2O2 production but recent
work has also shown that ROS can also be emitted from the E1
subunit [20,22]. Pyruvate dehydrogenase (Pdh), an enzyme similar
in structure to Ogdh which commits carbohydrate degradation
product pyruvate to Krebs cycle metabolism, also serves as a redox
sensor, increasing and decreasing ROS production in response to
changes in mitochondrial redox buffering capacity [23]. Thus,
Ogdh not only serves as a redox sensor but through ROS formation
directly inﬂuences the state of the surrounding redox
environment.
Changes in nutrient metabolism and electron supply are at the
heart of cellular redox signaling [24]. It is thus critical to further
characterize the redox sensing properties of enzymes like Ogdh,
which provide a direct link between carbon ﬂux and changes in
redox environment. Here, we hypothesized that S-glutathionyla-
tion reactions would control ROS genesis by Ogdh. It was reasoned
that a low GSH/GSSG, driven by an increase in GSSG, would
spontaneously S-glutathionylate Ogdh diminishing its activity
while simultaneously suppressing ROS production. Likewise a high
GSH/GSSG of 10–100 would have the opposite effect, restoring
Ogdh activity while driving ROS production back up to control
levels. GSSG at mM concentrations, which would only be found in
mitochondria experiencing oxidative stress, led to S-glutathiony-
lation of Ogdh lowering ∙−O2 /H2O2 production and 2-oxoglutarate
oxidation. However, it was unexpectedly found that GSH ampliﬁed
∙−O2 /H2O2 production while simultaneously suppressing NADH
production. In addition, Grx2 reversed these effects showing that
this ampliﬁcation can be reversed and is thus controlled. Collec-
tively, our results point to the existence of a regulatory mechanism
that involves the Ogdh-mediated sensing of changes in mi-
tochondrial redox environment where a reduced glutathione pool
can feed back and amplify ROS production which can be reversed
by activated Grx2.2. Experimental procedures
2.1. Reagents
Puriﬁed Ogdh from porcine heart (α-ketoglutarate dehy-
drogenase; Sigma Catalog Number K1502), Grx2 (human re-
combinant protein puriﬁed from Escherichia coli, Sigma Catalog
Number G6673), mannitol, sucrose, EGTA, and Hepes, 2-ox-
oglutarate, NADþ , NADH, NADPH, GR, GSH, GSSG, hydroxyethyl
disulﬁde (HEDS), thiamine pyrophosphate (TPP), Coenzyme A
(CoASH), 3-methyl-2-oxopentanoic acid (KMV) and horseradish
peroxidase (HRP), superoxide dismutase (SOD), catalase (CAT),
alamethicin, 1-chloro-2,4-dinitrobenzene (CDNB), and defatted
BSA were purchased from Sigma. Amplex UltraRed (AUR) were
purchased from Invitrogen.
2.2. Ogdh assays
Ogdh was examined essentially as described previously with a
few modiﬁcations [20,25]. All assays were conducted in MESH
buffer (220 mM mannitol, 90 mM sucrose, 20 mM Hepes, 1 mM
EGTA, pH 7.4) at 25 °C. Ogdh was diluted to 20 mU/mL in MESH
containing 0.3 mM TPP, and 0.1 mM CoASH and allowed to equi-
librate for 5 min at 25 °C. NADþ (1 mM) was then added followed
by initiation of reactions with 2-oxoglutarate (ﬁnal concentration
range from 0.1 to 20 mM). For most assays, reactions were drivenby 10 mM 2-oxoglutarate unless stated otherwise. Formation of
NADH was monitored over 10 min at 30 s intervals and tracked by
autoﬂuorescence (ex:em; 376:420) using a Synergi MX2 mono-
chromatic microplate reader (BioTek). Amount of NADH produced
was quantiﬁed using standard curves and Gen5 software. To test
the impact of glutathione on its activity, Ogdh was preincubated in
GSH (1–10 mM), GSSG (0.01–10 mM), or a combination of GSH and
GSSG for 5 min at 25 °C prior to enzyme equilibration. Note that
GSH and GSSG were utilized in different combinations to examine
if changes in GSH/GSSG redox potential affected Ogdh. For KMV
assays Ogdh was pre-incubated for 5 min in KMV prior to con-
ducting any assays. For Grx2 assays, immediately prior to initiating
Ogdh activity reaction mixtures were supplemented with Grx2
and GSH at a ﬁnal concentration of 0.5 mM and 1 mM respectively.
Note that GSH is required to drive Grx2 activity. Rate calculations
were based on the linear part of the curves (within ﬁrst 3 min of
the assay). The condition of Ogdh was examined prior to experi-
ments by testing its activity in the absence or presence of 1 mM
DTT.
2.3. Amplex Ultra Red (AUR) assays
Measurement of ∙−O2 /H2O2 was conducted as described in [25].
Ogdh was treated with GSH, GSSG or GSHþGSSG and then equi-
librated in MESH as described above. Mixtures were then sup-
plemented with 3 U/mL HRP, 25 U/mL SOD, and 5 μM AUR and
reactions were started by addition of 2-oxoglutarate with NADþ or
with NADH (0.5–100 μM). Note that for experiments testing
∙−O2 /H2O2 formation during RET TPP and CoASH were excluded.
∙−O2 /H2O2 formation was monitored ﬂuorometrically at ex:em
565 nm:600 nm. Speciﬁcity of AUR towards H2O2 formation was
conﬁrmed by including 10 U/mL CAT in reaction mixtures.
2.4. Grx2 activity measurement
Grx2 activity was examined by HEDS assay as described in [26].
HEDS was diluted to 1.8 mM in MESH containing 0.9 mM GSH and
allowed to incubate at 25 °C for 30 min. Reaction mixtures were
then supplemented with 0.5 μM Grx2 and 0.4 U/mL GR and then
allowed to equilibrate for 5 min. Reactions were initiated by the
addition of 1 mM GSH followed by 0.2 mM NADPH. Reactions were
monitored over 5 min with measurements taken at 30 s intervals.
NADPH consumption was tracked by autoﬂuorescence (em:ex,
376 nm:450 nm). To ascertain if (1) Ogdh could undergo S-glu-
tathionylation by GSH and (2) if Ogdh was a substrate for Grx2,
Ogdh was incubated in 5 mM GSH for 5 min at 25 °C followed by
the addition of Grx2, GSH, GR, and NADPH.
2.5. Preparation of liver mitochondria
All animal experiments were approved by Memorial Uni-
versity's Animal Care and Use committee. All steps were per-
formed on ice or 4 °C unless stated otherwise. Mitochondria were
enriched from the livers of male C57BL/6N mice purchased from
Charles River Laboratories. Mice (9–10 weeks old) were eu-
thanized by cerebral dislocation under isoﬂurane anesthesia, livers
were placed in MESH containing 0.5% defatted BSA (MESH-B). Li-
vers were cut into small pieces, washed several times to remove
excess blood and then homogenized on ice in MESH-B using the
Potter–Elvejham method. Homogenates were centrifuged at
800 g for 9 min after which fat was carefully skimmed off the top
of the supernatant. The supernatant was collected, centrifuged at
10,000 g for 9 min to pellet mitochondria, and then decanted.
Sides of the tubes were wiped carefully to remove any access fat.
Mitochondrial pellets were then resuspended in 10 mL of MESH-B
and centrifuged at 10,000 g for 9 min. The ﬁnal mitochondrial
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assays. Protein content was quantiﬁed by Bradford Assay.
Mitochondria were diluted to 5 mg/mL in pre-warmed MESH-B
containing 10 μM CDNB. Suspensions were vortexed vigorously
and then incubated for 10 min at room temperature. Previous
studies have established that 10 μM CDNB is adequate to deplete
mitochondria of GSH [25]. Suspensions were then centrifuged for
5 min at 10,000 g and washed twice with ice-cold MESH-B to
remove any excess CDNB. Mitochondria were then resuspended in
1 mL MESH-B containing 40 μg/mL alamethicin and incubated for
5 min at 37 °C to permeabilize mitochondria [20]. Suspensions
were diluted by 2.5-fold in ice-cold MESH-B and centrifuged for
15 min at 30,000 g. Permeabilized mitochondrial pellets were
then resuspended in MESH-B at a ﬁnal concentration of 3 mg/mL
for assays. Efﬁcacy of permeabilization was tested by measuring
the activity of malate dehydrogenase (Mdh) [27]. Ogdh activity
and ∙−O2 /H2O2 production and the effects of GSH and Grx2 were
examined essentially as described above. Assays were conducted
on permeabilized mitochondria diluted to a ﬁnal concentration of
0.3 mg/mL.
2.6. Mitochondrial GSH levels
Mitochondrial glutathione levels were determined using 5,5′-
dithio-bis(2-nitro-benzoic acid; DTNB). Brieﬂy mitochondria were
treated with or without CDNB and then permeabilized as de-
scribed above followed by incubation in 5 mM GSH for 5 min at
25 °C. Mitochondria were then pelleted and resuspended at a ﬁnal
concentration of 5 mg/mL in 10% trichloroacetic acid solution and
then allowed to incubate on ice for 10 min. Precipitated protein
was pelleted by high speed centrifugation and the supernatant
was collected and stored on ice. The pH was neutralized with 6 N
KOH and then diluted 2-fold with pre-warmed MESH containing
0.2 mM DTNB. Reactions were then incubated at 37 °C for 30 min.
Color changes were monitored at A412. GSH levels were quantiﬁed
using standard curves with a GSH concentration range of 0.1–
10 mM.
2.7. Immunoblotting
Puriﬁed Ogdh was diluted to 2 mg/mL in MESH and incubated
for 10 min at 25 °C in 1 or 10 mM GSSG, or 5 mM GSH in a ﬁnal
volume of 150 μL. For reactions involving Grx2, following the
15 min incubation, samples were then incubated for an additional
5 min in 1 mM Grx2þ2 mM GSH. Reactions were then stopped by
adding 1 volume of RIPA buffer containing 25 mM N-ethylmalei-
mide (NEM). After a 5 min incubation at room temperature reac-
tion mixtures were diluted with a volume of sample buffer with or
without 2% (v/v) 2-mercaptoethanol. The ﬁnal concentration of
Ogdh was 0.5 mg/mL and 25 mL of sample was loaded per well
giving a ﬁnal amount of 12 mg of protein. Anti-Ogdh(Abcam) was
used at a ﬁnal dilution of 1:5000 and protein-glutathione mixed
disulﬁde (PSSG) anti-serum (Virogen) was diluted to 1:1000. Pri-
mary antibodies were prepared in TBS-T containing 5% (w/v) fatty
acid-free BSA and 0.02% (w/v) sodium azide. Secondary antibodies
were horse radish peroxidase conjugated goat anti-rabbit and goat
anti-mouse (1:3000), respectively. Proteins were detected using
Supersignal West Pico (Thermo Scientiﬁc) and bands were visua-
lized with ImageQuant LAS 4000 (GE Health Care Life Sciences).
2.8. Data analysis
For puriﬁed enzyme assays all experiments were performed
4 times and in duplicate. Permeabilized mitochondria experiments
were performed 6 times and in quadruplicate. Western blots were
performed in duplicate except for blots in Fig. 6d which wereperformed 4 times and then quantiﬁed for band intensity with
ImageJ software. All results were analyzed using GraphPad Prism
6 software.3. Results
3.1. GSSG lowers ∙−O2 /H2O2 formation by puriﬁed Ogdh
Previous studies have shown that Ogdh can undergo S-glu-
tathionylation which can limit its activity [28]. In particular it was
found that S-glutathionylation was potentiated by oxidation of
vicinal lipoamide thiols on the E2 subunit of Ogdh resulting its
S-glutathionylation which is required to protect the enzyme
complex from irreversible deactivation [28]. However, it has also
been found that GSSG at mM concentrations can also drive
S-glutationylation of Ogdh on all three subunits [29]. To ascertain
if Ogdh was (1) sensitive to S-glutathionylation by GSSG and (2) if
GSSG induced S-glutathionylation modulates ∙−O2 /H2O2 formation
by Ogdh, a series of experiments were carried out to examine if
S-glutathionylation can control ROS production by Ogdh. The ca-
pacity of puriﬁed Ogdh to generate ∙−O2 /H2O2 by RET from NADH
was ﬁrst conﬁrmed Fig. 2a. A concentration dependent increase in
∙−O2 /H2O2 formation was observed with increasing NADH con-
centration (Fig. 2a). Speciﬁcity of Amplex Ultra Red for H2O2 was
conﬁrmed with catalase (CAT) which completely abolished any
ﬂuorescence. Incubation in 1 mM GSSG suppressed ∙−O2 /H2O2 for-
mation by puriﬁed Ogdh in the presence of 5–100 mM NADH
(Fig. 2b). Exposure of puriﬁed Ogdh to varying concentrations of
GSSG revealed that at least 1 mM GSSG was required to sig-
niﬁcantly suppress NADH-driven ∙−O2 /H2O2 formation (Fig. 2c).
∙−O2 /H2O2 production decreased further (2.5 fold) in the presence
of 10 mM GSSG (Fig. 2c). Next, we utilized anti-serum directed
against PSSG adducts to ascertain if these effects were associated
with S-glutathionylation of Ogdh. As shown in Fig. 2d, incubation
of Ogdh in GSSG caused a concentration dependent increase in an
immunoreactive band at between 65 and 75 kDa which corre-
sponded to the molecular weight of the E2 subunit of Ogdh. In-
clusion of β-mercaptoethanol conﬁrmed the speciﬁcity of anti-
PSSG antibody towards S-glutathionylation adducts. These results
conﬁrm that GSSG can S-glutathionylate Ogdh through a simple
disulﬁde exchange reaction.
It has been demonstrated that Ogdh also generates ∙−O2 /H2O2
when oxidizing 2-oxoglutarate in the presence of NADþ [20]. Thus
we set out to examine the effect of GSSG on Ogdh kinetics and if
GSSG could alter ∙−O2 /H2O2 production when Ogdh is oxidizing
2-oxoglutarate in the presence of NADþ . Puriﬁed Ogdh from Sigma
is reported to have contaminating levels of pyruvate dehy-
drogenase (Pdh). Thus, the activities of Ogdh and Pdh were ex-
amined in the puriﬁed Ogdh mixture. As shown in Fig. 3a, Ogdh
makes up 90% of the total activity of the preparation with Pdh
making up the remaining 10%. With this it is expected that
contaminating Pdh will interfere minimally with these assays,
especially since reactions are being driven by 2-oxoglutarate. GSSG
at 1 mM was required to signiﬁcantly lower Ogdh activity which
decreased further when exposed to 10 mM GSSG (Fig. 3b). Fur-
thermore, exposure to 1 mM GSSG decreased the Vmax for 2-ox-
oglutarate (Fig. 3c). No change in Km for 2-oxoglutarate was found
indicating GSSG is a non-competitive inhibitor. To assess the re-
lationship between NADH formation and ∙−O2 /H2O2 genesis in the
presence of GSSG, both NADH and ∙−O2 /H2O2 production were
monitored simultaneously. For these assays, the concentration of
NADþ was kept constant at 0.1 mM (Fig. 3d and e). Addition of
2-oxoglutarate resulted in the rapid conversion of NADþ to NADH
gradually reaching steady state at 2–3 min (Fig. 3d). This was as-
sociated with a linear increase in H2O2 production over 10 min.
Fig. 2. GSSG mildly suppresses ∙−O2 /H2O2 through S-glutathionylation of its E2 subunit. (A) Puriﬁed Ogdh complex generates
∙−O2 /H2O2 from reverse electron transfer from
NADH. Puriﬁed Ogdh was treated with different concentrations of NADH (0–100 μM) and then ∙−O2 /H2O2 production was measured using Amplex Ultra Red (AUR). Catalase
(CAT) was included (10 U/mL) as a control to ensure AUR was speciﬁc for H2O2. (B) Impact of GSSG on ∙−O2 /H2O2 production from puriﬁed Ogdh complex oxidizing NADH.
Reactions were conducted as in A except Ogdh was pre-incubated in 1 mM GSSG prior to initiating reactions. n¼4, 2-way ANOVA with Tukey's post-hoc test. (C) Effect of
different GSSG concentrations on ∙−O2 /H2O2 formation by reverse electron ﬂow. Puriﬁed Ogdh was pre-incubated in GSSG (0–10 mM) and then
∙−O2 /H2O2 production was
examined by AUR using 5 microM NADH as the substrate. n¼4, 1-way ANOVAwith Tukey's post-hoc test. (D) Examination of GSSG-mediated S-glutathionylation of Ogdh by
immunoblot. Protein glutathione mixed disulﬁde (PSSG) formation was examined using anti-PSSG antibody. Speciﬁcity of anti-PSSG towards glutathionylated protein was
assured by running gels under reducing conditions (þβM; 2% β-Mercaptoethanol added to sample buffer). E1 subunit (110 kDa) was detected using anti-E1 antibody. All
three subunits were detected by Ponceau S staining of blots. Stains were documented and individual molecular weights for each subunit were estimated using a molecular
weight marker and ImageQuant software.
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(Pdh) where ∙−O2 /H2O2 formation was reported to be directly pro-
portional to NADH levels [25]. Pre-incubation of Ogdh with 1 mM
GSSG induced a small but signiﬁcant decrease in both the rate of
NADH and ∙−O2 /H2O2 production (Fig. 3d and e). When GSSG was
included in reaction mixtures NADH production began to level off
later reaching steady state at 4 min (Fig. 3d and e). To examine
the effect of GSSG on Ogdh kinetics further, NADH and ∙−O2 /H2O2
production was measured simultaneously before and after addi-
tion of NADþ (Fig. 3f and g). As noted in Fig. 3f, rates of NADH
formation were negligible the absence of NADþ which was asso-
ciated with a rapid production of ∙−O2 /H2O2. Addition of NAD
þ to
reaction mixtures suppressed ∙−O2 /H2O2 production, which coin-
cided with a robust increase in NADH formation (Fig. 3f). Thus, in
the absence of NADþ Ogdh generates high amounts of ∙−O2 /H2O2
due to the diversion of electrons from 2-oxoglutarate towards the
univalent reduction of O2 and the production of ROS. Pre-incuba-
tion of Ogdh in 1 mM GSSG induced a signiﬁcant decrease in
∙−O2 /H2O2 production before and after the addition of 0.1 mM NAD
demonstrating that S-glutathionylation by GSSG can induce a mild
but signiﬁcant decrease in ROS production when Ogdh is oxidizing
2-oxoglutarate (Fig. 3g). Considering that GSSG is typically
0.1 mM it can be assumed that GSSG-mediated S-glutathiony-
lation of Ogdh may only occur in mitochondria experiencing oxi-
dative stress (e.g. there is sufﬁcient ROS accumulation to promptan increase in GSSG to the mM range) [14]. Taken together, these
results indicate that GSSG at mM concentrations can weakly react
with Ogdh to induce S-glutathionylation on the E2 subunit of Ogdh
which mildly suppresses ∙−O2 /H2O2 formation with a concomitant
decrease in Ogdh activity.
3.2. GSH ampliﬁes ∙−O2 /H2O2 by Ogdh
Since the mitochondrial matrix usually contains both GSH and
GSSG which can vary in concentration creating highly localized
redox gradients we decided to examine the effects of different
GSH/GSSG ratios on puriﬁed Ogdh kinetics. We postulated that
while a low GSH/GSSG would impede Ogdh function limiting
∙−O2 /H2O2 formation, a high GSH/GSSG would have the opposite
effect restoring Ogdh function back to control levels. For this set of
experiments, Ogdh was pre-incubated in different concentrations
of GSH and GSSG clamping GSH/GSSG at 0.1, 1, 10 and 100 (Fig. 4a
and b). The calculated redox potentials for each glutathione pair
are shown in Fig. 4b. After the pre-incubation, reactions were in-
itiated by addition of 2-oxoglutarate followed by simultaneous
measurement of NADH and ∙−O2 /H2O2 formation (Fig. 4a). We found
that the presence of high GSSG (1 mM) and low GSH (0.1 and
1 mM), which clamped the GSH/GSSG at 0.1 and 1, respectively,
induced a small but signiﬁcant decrease in ∙−O2 /H2O2 production
(Fig. 4a and b). At a GSH/GSSG ratio of 1, this was also associated
Fig. 3. GSSG lowers the rate of ∙−O2 /H2O2 by Ogdh when oxidizing 2-oxoglutarate with NAD
þ . (A) Assessment of Ogdh purity. Activity of Ogdh and Pdh were examined as
described in Materials and Methods except 1 mM 2-oxoglutarate or pyruvate were used to assess overall activity. (B) GSSG decreases the activity of Ogdh. Puriﬁed Ogdh was
incubated in varying amounts of GSSG (0–10 mM) and then the activity examined in the presence of TPP (0.3 mM), CoASH (0.1 mM), NADþ (1 mM), and 2-oxoglutarate
(10 mM). (C) Effect of GSSG on Ogdh kinetics. After pre-incubating Ogdh in 1 mM GSSG rate of NADH production was measured in response to varying amounts of
2-oxoglutarate. Km and Vmax values with respect to NADH formation were calculated using Graphpad Prism software. (D) Representative traces for the simultaneous
measurement of the effect of 1 mM GSSG on ∙−O2 /H2O2 and NADH production. Reactions were initiated by the addition of 2-oxoglutarate (OG; 10 mM). Traces were then
utilized to calculate the rate of ∙−O2 /H2O2 and NADH production (E). (F) Traces measuring the effect of GSSG on
∙−O2 /H2O2 and NADH production production by Ogdh as a
function of the absence and presence of NADþ . Reactions were initiated by the addition of 2-oxoglutarate without any NADþ , measured for 3 min, and then NADþ was
added to a ﬁnal concentration of 1 mM. Traces were utilized to calculate rate of ∙−O2 /H2O2 and NADH production before and after addition of NAD
þ (G). n¼4, 1-way ANOVA
with Tukey's post-hoc test.
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contrary to our hypothesis we found that high GSH/GSSG (10 and
100) completely abolished NADH formation (Fig. 4a and b). This
change in Ogdh function coincided with an increase in ∙−O2 /H2O2
production (Fig. 4a and b). CoASH can form adducts with GSH
which could interfere with assay conditions which could be the
reason for the increased production of ROS by Ogdh when pre-incubated with GSH. We thus decided to test the effect of the
absence of CoASH on ∙−O2 /H2O2 production. Exclusion of CoASH
induced 70% drop in ∙−O2 /H2O2 production formation by the
complex (Fig. 4c). Notably Ogdh still retained some ROS forming
capacity which is likely associated with production by the E1
subunit. Also exclusion of CoASH abolished Ogdh activity. By way
of contrast pre-incubation of Ogdh with GSH at a ﬁnal
Fig. 4. Effect of varying GSH/GSSG on Ogdh function. (A) Simultaneous examination of the effect of different GSH/GSSG ratios on ∙−O2 /H2O2 and NADH production by puriﬁed
Ogdh. (B) Traces from A were utilized to calculate the rate of ∙−O2 /H2O2 and NADH production. GSH/GSSG ratios were achieved by varying the ﬁnal concentrations of GSH and
GSSG in reaction mixtures. The redox potential (Eh) obtained in the reaction mixtures was calculated using the Nernst equation. (C) Effects of GSH on Ogdh are not due to
glutathione-mediated depletion of CoASH. n¼4, 1-way ANOVA with Tukey's post-hoc test.
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production (Fig. 4c). This was also associated with a loss in Ogdh
activity.
The unexpected nature of these ﬁndings prompted us to ex-
amine the impact of GSH on puriﬁed Ogdh further. In this next set
of experiments, Ogdh was treated with different concentrations of
GSH to pinpoint the concentration required to induce an increase
in ROS production while simultaneously suppressing its activity.
As shown in Fig. 5a and b, pre-incubation of Ogdh in increasing
GSH concentrations led to a progressive augmentation of ∙−O2 /H2O2formation reaching a peak of 3.5-fold at 5 mM GSH. The lowest
concentration of GSH required to induce this effect was 2.5 mM
GSH which increased ∙−O2 /H2O2 formation by 2.4-fold (Fig. 5a and
b). This effect was associated with a signiﬁcant decrease in NADH
formation (33% decrease in activity). Concentrations of
GSHZ5 mM completely abolished NADH production amplifying
∙−O2 /H2O2 production further. Thus, when exposed to 2.5 mM GSH
Ogdh retains 67% of its activity which is associated with a 2.4-
fold increase in ROS production. These ﬁndings prompted us to
construct dose response curves to pinpoint the concentration of
Fig. 5. GSH alters electron ﬂux in puriﬁed Ogdh resulting in ampliﬁed ∙−O2 /H2O2 production. (A) Representative traces showing the effect of different GSH concentrations (0–
10 mM) on ∙−O2 /H2O2 and NADH production. Note that GSHZ5 mM completely abolishes NADH formation. Traces were utilized to calculate rates of
∙−O2 /H2O2 and NADH
production (B). (C) Dose–response curves for the effect of GSH on Ogdh activity and ∙−O2 /H2O2 formation. (D) Impact of Ogdh inhibitor 3-methyl-2-oxopentanoic acid (KMV)
on ∙−O2 /H2O2 and NADH production in the presence or absence of 5 mM GSH. (E) Autooxidation of AUR by different reaction mixture components. Calculated rates
∙−O2 /H2O2
production were compared to reactions containing Ogdh and Ogdhþ5 mM GSH. Note that GSH (5 mM) and dithiol DTT (5 mM) induce a small change in the rate of AUR
conversion to resoruﬁn. (F) GSH has little effect on the rate of ∙−O2 /H2O2 production during reverse electron transfer from NADH. Reactions were initiated by the addition of
NADH (5 mM) and then the reaction of AUR with H2O2 was measured. n¼4, 1-way ANOVA with Tukey's post-hoc test.
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decrease in Ogdh activity. Dose response curve calculations re-
vealed that 2.125 mM GSH was required to induce a 50% increase
in ∙−O2 /H2O2 formation by Ogdh while 2.819 mM was required to
induce a 50% decrease in activity (Fig. 5c). Considering that con-
centrations of GSH in mitochondria are found between 1 and
5 mM we can conclude that physiologically relevant concentra-
tions of GSH can induce signiﬁcant changes in Ogdh activity and
∙−O2 /H2O2 formation [7,15]. Also, considering ROS production and
redox buffering are also in a constant state of ﬂux it can be pre-
sumed that if GSH concentrations dip below 2 mM, Ogdh can re-
tain a higher NADH and lower ROS production proﬁle [24].
To conﬁrm that GSH was amplifying ROS production reactions
were performed in the presence of Ogdh inhibitor KMV. KMV
impedes Ogdh activity by blocking the 2-oxoglutarate binding site
on the E1 subunit. Inclusion of KMV induced a decrease ∙−O2 /H2O2
formation in control reactions conﬁrming that this compound isable to inhibit ROS formation via blockage of the 2-oxoglutarate
binding site of Ogdh (Fig. 5d). Note that it has been shown that
KMV does not completely inhibit Ogdh activity [20]. Incubation of
Ogdh in 5 mM GSH led to a robust increase in ∙−O2 /H2O2 production
which was prevented by KMV (Fig. 5d). It has been reported GSH
can autooxidize Amplex Red generating a ﬂuorescence comparable
to respiring mitochondria [30]. Thus we tested if GSH, 2-ox-
oglutarate, NADþ or dithiol DTT could interfere with Amplex Red.
GSH and DTT induced a small increase in detectable ﬂuorescence
but this was signiﬁcantly surpassed by the rate of production
by Ogdh in the absence or presence of GSH (Fig. 5e). The impact
of GSH on NADH-driven ∙−O2 /H2O2 formation was also measured
(Fig. 5f). We found that GSH induced a small decrease in ∙−O2 /H2O2
production during RET indicating GSH impedes Ogdh upstream
of the E3 subunit. Collectively, these results indicate that
the concentrations of GSH normally found in mitochondria am-
pliﬁes ∙−O2 /H2O2 production by Ogdh by redirecting electron
Fig. 6. Glutaredoxin-2 (Grx2) targets Ogdh for deglutathionylation reversing GSH-mediated ampliﬁcation of ∙−O2 /H2O2 formation. (A) Schematic depiction of the Grx2-
mediated deglutathionylation of target proteins. Successful deglutathionylation requires GSH which is utilized to ﬁnalize the catalytic cycle of Grx2. (B) Grx2 reverses the
GSH-mediated ampliﬁcation and ∙−O2 /H2O2 formation and abolishment of NADH production. Puriﬁed Ogdh was pre-incubated with or without GSH (5 mM) and then assayed
for ∙−O2 /H2O2 and NADH production. Puriﬁed Grx2 (0.5 mM) was added with GSH (1 mM) immediately before starting measurements. Reactions were initiated by the addition
of 2-oxoglutarate (10 mM). (C) Ogdh is a substrate for Grx2. Grx2 activity was assayed as described in Materials and Methods. To ensure Grx2 was enzymatically active, its
activity was measured using the hydroethyl disulﬁde (HEDS) assay. To test if Ogdh is a target for Grx2, Ogdh was preincubated in GSH (5 mM) and then Grx2 (0.5 mM) was
added in combination with GSH, GR, and NADPH. Grx2 activity is associated with the consumption of NADPH. Representative traces were utilized to calculate the rate of
NADPH consumption (D). (D) Assessment of protein glutathione mixed disulﬁde (PSSG) formation by GSH. Ogdh was incubated in 5 mM GSH and then with or without
Grx2þ1 mM GSH and then examined for PSSG levels. Following this membranes were stripped and reprobed for Ogdh E1 subunit as a loading control. Immunoreactivity of
PSSG towards its anti-serum was conﬁrmed be performing electrophoresis under reducing conditions (þβM; 2% β-Mercaptoethanol added to sample buffer). PSSG im-
munoreactive bands were quantiﬁed using ImageJ software. n¼4, 1-way ANOVA with Tukey's post-hoc test.
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subunit.
3.3. Ogdh is a target for Grx2-mediated protein deglutathionylation
Grx2 is responsible for deglutathionylating target proteins in
mitochondria in the presence of GSH ( Fig. 6a). Following a round
of deglutathionylation GSSG is reduced in the presence of NADPH
and GR. Based on this experiments were conducted to determine if
Grx2 at concentrations found in mitochondria (0.5 μM) could
reverse the GSH mediated ampliﬁcation of ∙−O2 /H2O2 production.
Pre-incubation of puriﬁed Ogdh in 5 mM GSH enhanced ∙−O2 /H2O2
with the concomitant abolishment of NADH formation (Fig. 6b).
Addition of Grx2 with 1 mM GSH partially recovered Ogdh activity
which was associated with a concomitant decrease in ROS pro-
duction (Fig. 6b). We next sought to ascertain if Ogdh pre-in-
cubated in GSH could serve as a substrate for Grx2. Enzymatic
activity of Grx2 operates in three stages; (1) catalytic N-terminal
cysteine of Grx2 displaces the glutathionyl moiety from protein
glutathione mixed disulﬁde (PSSG) resulting in the formation of a
glutathionyl-Grx2 (Grx2-SG) intermediate, (2) GSH binds Grx2-SG
resulting in the deglutathionylation of Grx2 and the formation of
GSSG, and (3) GSSG is oxidized by glutathione reductase (GR) in
the presence of NADPH to yield 2 GSH (Fig. 6a) [31]. To test if Grx2
could deglutathionylate Ogdh we utilized a modiﬁed hydro-
xyethyldisulﬁde (HEDS) assay where Ogdh pre-incubated in 5 mMGSH served as the Grx2 substrate. The HEDS assay revealed that
Grx2 was enzymatically active (Fig. 6c). Reactions in the absence of
Grx2 showed that NADPH was not spontaneously oxidized
(Fig. 6c). Inclusion of Grx2 in reaction mixtures containing Ogdh
pre-incubated in GSH stimulated the GR-mediated consumption of
NADPH at almost half the rate observed with the HEDS assay
(Fig. 6c). This result would suggest that Ogdh pre-incubated in
GSH could serve as a substrate for Grx2. Next, immunoblot was
conducted to determine if GSH could modify Ogdh by S-glu-
tathionylation. As shown in Fig. 6d, GSH induced a robust increase
in the presence of an immunoreactive band at 110 kDa which
would correspond to the E1 subunit of puriﬁed Ogdh. Reactions
that included Grx2 with 1 mM GSH lowered the intensity of this
immunoreactive band (Fig. 6d). This would indicate that GSH and
GSSG have different S-glutathionylation targets in Ogdh. Inclusion
of 2% β-mercaptoethanol in the preparations abolished the im-
munoreactivity of this band towards anti-PSSG (Fig. 6d). These
results illustrate that GSH ampliﬁes ROS formation by Ogdh by
blocking electron ﬂow through modiﬁcation of the E1 subunit.
These effects are reversed by the Grx2-mediated deglutathiony-
lation of Ogdh.
3.4. GSH ampliﬁes ∙−O2 /H2O2 production by Ogdh in liver mitochon-
dria which is reversed by Grx2
The results above show that puriﬁed Ogdh derived from
Fig. 7. Result of GSH and Grx2 on Ogdh-mediated ∙−O2 /H2O2 in liver mitochondria. (A) Effectiveness of alamethicin in permeabilizing mitochondria was tested by measuring
malate dehydrogenase (Mdh) activity. Mitochondria were depleted of GSH by CDNB, permeabilized, and then re-supplemented with GSH (5 mM) or Grx2 (0.5 mM)þ1 mM
GSH. Reaction mixtures consisted of NADþ (1 mM) and measurements were initiated following addition of malate. (B) CDNB depletes mitochondrial glutathione. Mi-
tochondria were treated with or without CDNB (10 mM), permeabilized with alamethicin (40 mg/mL). Glutathione levels were estimated using Ellman's reagent. To ensure
that GSH added to reaction mixtures could penetrate the matrix, permeabilized mitochondria pre-incubated in CDNB were re-supplemented with 5 mM GSH. (C and D)
Exogenously added GSH ampliﬁes ∙−O2 /H2O2 production by Ogdh which is reversed by glutaredoxin-2 (Grx2). Incubations were performed as described in A after which
∙−O2 /H2O2 genesis and NADH production were examined. n¼6, 1-way ANOVA with Tukey's post-hoc test.
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periods with physiologically relevant concentrations of GSH. This
is correlated with a burst in ROS production which was associated
with a decrease or complete loss in Ogdh activity, which was
highly dependent on GSH concentration. These effects could be
reversed by Grx2, a thiol oxidoreductase known to catalyze de-
glutathionylation of proteins. Next, we tested whether GSH could
elicit the same effects on mitochondria isolated from mouse liver.
Mitochondria contain 1–5 mM GSH and are impermeable to most
of the reagents used in this study. Thus, prior to conducting ex-
periments, mitochondria were depleted of endogenous GSH using
CDNB, which takes advantage of the catalytic action of en-
dogenous glutathione S-transferase to irreversibly conjugate CDNB
to GSH [32]. CDNB is utilized routinely to deplete mitochondrial
GSH [23,25] but it is worthy to point out that CDNB does interfere
with other antioxidant enzymes like thioredoxin reductase but
this does not preclude its use to study the effects of GSH manip-
ulations on Ogdh activity [32]. After CDNB treatment to ensure any
residual CDNB was removed mitochondria were washed and then
permeabilized with alamethicin to facilitate matrix uptake of Ogdh
substrates and manipulation of matrix GSH. Mitochondrial per-
meability was conﬁrmed by measuring malate dehydrogenase
activity which requires NADþ to drive the formation of ox-
aloacetate (Fig. 7a). We also conﬁrmed (1) that CDNB depleted
endogenous GSH and (2) exogenously added GSH could gain ac-
cess to the matrix environment (Fig. 7b). These control experi-
ments conﬁrm that CDNB is effective at depleting GSH and that
after depletion GSH levels can be experimentally manipulated in
permeabilized mitochondria.
Pre-incubation of mitochondria with 5 mM GSH induced a
substantial increase in ∙−O /2 H2O2 formation which was associated
with a decrease in NADH production (Fig. 7c and d). However,
unlike puriﬁed Ogdh, NADH formation was not completelyabolished which may be due to the fact that other NADH and
NADPH producing enzymes are still active in the matrix (Fig. 7c
and d). Adding enzymatically active Grx2 to reaction mixtures
almost completely restored Ogdh-mediated NADH formation with
a concomitant suppression of ∙−O2 /H2O2 formation (Fig. 7c and d).
These results conﬁrm that 5 mM GSH can divert electrons away
from NADH production and towards ROS biosynthesis in mi-
tochondria. It is also important to note that mitochondria from
liver tissue also harbor endogenous Grx2 however; it is usually
maintained in an inactive state through formation of Grx2 dimers
through Fe–S chelation [33]. Indeed, Grx2 is only activated by Fe–S
disassembly which is mediated by ∙−O2 /H2O2 resulting in the re-
lease of enzymatically active Grx2 monomers [33].4. Discussion
Nutrient metabolism is at the root of redox signaling. Electrons
supplied by the combustion of carbon in mitochondria generate
NADH and NADPH in conjunction with ∙−O2 /H2O2, factors that alter
mitochondrial redox buffering networks in space and time con-
veying redox signals to the cell [24]. Mitochondria can contain up
to 12 ROS generating sites with Ogdh serving as a major source of
∙−O2 /H2O2 (Fig. 1a) [3,34,35]. In tandem with this, Ogdh is also a
major mitochondrial redox sensor modulating its activity in re-
sponse to changes in the local redox environment. Redox signals
like S-glutathionylation have been shown to control mitochondrial
ROS production [8]. However, whether or not redox signals like
S-glutathionylation control ROS production by Ogdh has remained
unexplored. In this investigation, we found that S-glutathionyla-
tion reactions modulate ROS formation by Ogdh in a highly un-
expected way. It was observed that GSSG and GSH control
∙−O2 /H2O2 production by Ogdh. The former lowered
∙−O2 /H2O2
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posite effect, amplifying ∙−O2 /H2O2 production at the expense of
NADH formation. Grx2 reversed the GSH-mediated effects by de-
glutathionylating Ogdh. These ﬁndings indicate that Ogdh may
play a crucial role in sensing overall changes in mitochondrial
redox buffering networks which feedback to either amplify or
reduce the production of ROS by this Krebs cycle enzyme. These
ﬁndings are also consistent with observations that Pdh also senses
changes in mitochondrial redox buffering networks which ulti-
mately modulates its activity and capacity to produce ROS [23,25].
It was conﬁrmed that Ogdh can undergo S-glutathionylation
when exposed to Z1 mM GSSG which results in PSSG formation
on the E2 subunit. GSSG-mediated S-glutathionylation resulted in
a small but signiﬁcant decrease in ∙−O2 /H2O2 formation during
forward or reverse electron transfer. Incubation in 10 mM GSSG
led to a further decrease in ROS formation which was associated
with the increased S-glutathionylation of the E2 subunit. Recent
work has found that Ogdh produces ROS from both the E1 and E3
subunits which accounts for the GSSG-mediated decrease in
∙−O2 /H2O2 formation when Ogdh is oxidizing either 2-oxoglutarate
or NADH [22]. It is important to point out though that GSSG at
1 mM, which occurs at this concentration only during oxidative
stress and when ROS formation is very high, only weakly inhibited
Ogdh function and ROS production. In three separate studies,
Szweda and colleagues provided empirical evidence that pre-oxi-
dation of lipoamide by H2O2 is required to drive the S-glutathio-
nylation of the E2 subunit [19,28,36]. It is therefore likely that
H2O2-mediated formation of sulfenic acid on the E2 subunit is
required to allow GSSG to more efﬁciently react with Ogdh. Thus,
we can conclude that although GSSG can induce mild suppression
of Ogdh ROS production, it does not seem likely that GSSG reacts
directly with Ogdh in physiological conditions. Rather formation of
reactive sulfenic acid moieties enhance S-glutathionylation
through disulﬁde exchange with GSSG. Moreover, S-glutathiony-
lation via a direct disulﬁde exchange reaction between thiols on
Ogdh and GSSG most likely only occurs when mitochondria are
faced with oxidative stress.
The mitochondrial redox buffering network is composed of a
number of different redox pairs [37]. Due to its high concentration
and negative redox potential glutathione is considered to be a
major redox buffering agent in most biological environments in-
cluding mitochondria [38]. Shifts in GSH/GSSG have been shown
to modulate various cellular signaling programs including cell di-
vision, growth, energy metabolism, and gene expression [37,39].
Enzymes like Pdh, a homolog of Ogdh, sense local changes in re-
dox environment which ultimately modulates its activity and the
amount of ROS it produces [23,25]. As indicated above, a lower
GSH/GSSG is typically associated with S-glutathionylation of target
proteins which lowers cellular ROS formation, in particular in
mitochondria [8]. Further, S-glutathionylation in mitochondria is
required to protect enzymes like Ogdh and Complex I from irre-
versible deactivation due to over-oxidation by ROS [19,40]. In
consideration of the profound effects variations in GSH/GSSG can
have on enzyme function, the impact of different GSH/GSSG ratios
on Ogdh activity and ROS production was investigated in detail.
We found that a low GSH/GSSG (0.1–1) slightly decreased Ogdh
activity and ∙−O2 /H2O2 production. This is consistent with our re-
sults showing that GSSG alone can induce a small but signiﬁcant
change in Ogdh function. Unexpectedly, adjusting GSH/GSSG to 10
and 100 abolished Ogdh activity amplifying ROS production.
Moreover, these effects were directly related to the concentration
of GSH and not associated with ﬂuctuations in GSH/GSSG. Indeed,
we found that GSH directly modulated Ogdh activity and ROS
production which was concentration dependent. At least
2.125 mM GSH was required to induce a 50% increase in ROS
production and 2.819 mM for inhibition of NADH production. It isimportant to point out that GSH is not maintained at a consistent
concentration in mitochondria. GSH levels are in a constant state
of ﬂux, increasing and decreasing in response to ﬂuctuations in
nutrient oxidation, H2O2 formation, and availability of NADPH [24].
Thus, based on our results, it follows that Ogdh activity and ROS
production will also be in a state of ﬂux, increasing and decreasing
in response to local changes in GSH availability.
It is now becoming apparent that cells employ a rich panoply of
systems to control ROS production to beneﬁt from its signaling
properties while simultaneously avoiding its toxic properties [41].
This includes various signaling pathways that includes electrophile
signaling, the unfolded and heat shock response, and redox acti-
vated autophagy [41]. Redox signals also feedback on sites of
production to control ROS formation and it is becoming increas-
ingly clear that these signals can either increase or decrease
∙−O2 /H2O2 production. Here, we found that GSH S-glutathionylates
Ogdh directly, speciﬁcally in the E1 subunit of the enzyme com-
plex. It has been reported in several studies that GSH can S-glu-
tathionylate proteins directly. This has been documented to occur
in the cytosol and mitochondria, respectively, and typically re-
quires formation of thiyl radicals, either on the protein being tar-
geted for modiﬁcation or on GSH itself [14]. For example, protein
cysteine thiyl radical formation on several cysteine residues on
Ndusf1 subunit drives the GSH-mediated S-glutathionylation of
Complex I, even when GSH/GSSG is high [42]. Protein cysteine
thiyl formation occurs when ∙−O2 is generated in proximity to
Complex I which prompts GSH-mediated S-glutathionylation and
the further production of ROS [43]. It is possible that GSH-induced
S-glutathionylation of Ogdh on its E1 subunit may be driven by a
similar mechanism [44]. In fact, Ogdh generates a number of in-
trinsic thiyl radicals which inevitably results in its inactivation
[45]. In this investigation, GSH S-glutathionylated the E1 subunit of
Ogdh conﬁrming the presence of redox modiﬁable cysteine re-
sidues. In addition, two previous studies have shown that E1 can
undergo S-glutathionylation [29,46]. It is also intriguing that GSSG
and GSH induced S-glutathionylation on two different subunits
indicating that both molecules have different targets for modula-
tion of ∙−O2 /H2O2 formation by Ogdh. This would suggest that Ogdh
utilizes its E1 and E2 subunits to differentially sense ﬂuctuations in
GSH and GSSG, respectively. While GSSG may block electron
transfer to sites of production GSH has the opposite effect on the
E1 subunit, amplifying ROS formation when Ogdh is metabolizing
2-oxoglutarate. Based on this it can be surmised that Ogdh senses
local changes in GSH levels which may be associated with auto-
oxidation of cysteine residues on the E1 subunit via thiyl radical
formation.
Protein S-glutathionylation reactions have also been shown to
enhance the formation of ROS. For instance, S-glutathionylation of
nitric oxide synthase (NOS) uncouples the enzyme amplifying ∙−O2
from its reductase subunit [47]. Intriguingly S-glutathionylation of
NOS is mediated by protein thiyl radical formation and its sub-
sequent reaction with GSH [47]. Similarly, prolonged S-glutathio-
nylation of Complex I, for example when Grx2 is disabled or fol-
lowing chemical induction of S-glutathionylation by diamide, re-
sults in the ampliﬁcation of ROS formation [15,48]. In this study,
GSH induced a robust increase in ∙−O2 /H2O2 formation by puriﬁed
Ogdh when 2-oxoglutarate was being oxidized in the presence of
NADþ . This was associated with S-glutathionylation of the E1
subunit and a complete loss of NADH formation. Similar observa-
tions were made in permeabilized liver mitochondria except
NADH production was not abolished but signiﬁcantly decreased.
Intriguingly, we observed that GSH only induced a small decrease
in ROS production during reverse electron transfer from NADH. In
addition, supplementing reaction mixtures containing 2-ox-
oglutarate and NADþ with KMV induced a signiﬁcant drop in
∙−O2 /H2O2 production. These results coupled with the observation
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GSH is likely amplifying ROS formation from the E1 subunit of
Ogdh rather than the E3 subunit. Indeed, the E3 subunit is often
considered the chief site for Ogdh mediated ROS formation how-
ever; recent evidence has shown that the E1 subunit also generates
ROS through production of thiamine radicals within the subunit
[22,49]. Taken together, GSH modiﬁes Ogdh resulting in diverted
electron ﬂow towards ampliﬁed ROS production from the E1
subunit.
GSH was also able to control Ogdh in the matrix of permeabi-
lized liver mitochondria. We found that GSH redirected electron
ﬂow from 2-oxoglutarate amplifying ∙−O2 /H2O2 genesis which also
lowered NADH production. In conjunction with these ﬁndings
adding Grx2 to permeabilized mitochondria treated with 5 mM
GSH reversed these effects. This indicates Grx2 can deglutathio-
nylate Ogdh in the mitochondrial matrix. It is important to note
that Grx2 lowered ROS production and restored NADH formation
back to control levels which may be associated with the presence
of endogenous NADPH-forming enzymes and GR. Only two Grx2
targets have been identiﬁed; Complex I and UCP3 [15,17]. Grx2 is
subjected to heavy regulation due to formation of inactive dimers
via coordination of a 2Fe–2S cluster [33]. ROS-mediated dis-
assembly of the Fe–S cluster results in the release of two Grx2
monomers harboring deglutathionylase activity [33]. Thus, GSH
mediated diversion of electron ﬂow in Ogdh and the ampliﬁcation
of ROS production would result in the activation of endogenous
Grx2 creating a feedback loop resulting in the deglutathionylation
of Ogdh and restoration of NADH production. Disabling this
feedback loop may also have pathological consequences. Grx2-/-
mitochondria generate higher than normal amounts of ROS which
may be related to prolonged ROS production by Ogdh [15].
Knockout of Grx2 is associated with development of cardiac dis-
ease, neurological disorders, and cataracts [15,50]. Grx2/ also
curtails cardiac, neural, and vascular development which is likely
associated with disrupted cellular redox buffering and nutrient
metabolism [51–53]. In addition, over production of ROS by either
the E1 or E3 subunits of Ogdh has been implicated in neurological
and cardiac disorders [18,22]. Sensing mitochondrial redox buf-
fering capacity has also recently been shown to modulate pyruvate
dehydrogenase (Pdh) [23,25]. Disabling mitochondrial redox cir-
cuits, chieﬂy through GSH depletion or disruption of NADPH for-
mation, directly ampliﬁes ROS formation by Pdh [23,25]. Together,
it would appear that both Ogdh and Pdh fulﬁll important redox
sensing functions in mitochondria modulating ROS emission and
carbon metabolism in response to ﬂuctuations in redox buffering
capacity. In light of the recently proposed Redox Code it is ap-
propriate that both Ogdh and Pdh serve as sensors for mitochon-
drial redox buffering capacity since both enzymes serve as im-
portant entry points for carbon into the Krebs cycle and would
thus inﬂuence overall redox signals throughout mitochondria and
in the cell [24].
The present ﬁndings reveal a novel signaling mechanism which
integrates mitochondrial redox buffering into control over mi-
tochondrial ROS production in a unique and highly unexpected
way. This network is centralized around the Ogdh-mediated sen-
sing of GSH levels which, if high enough, can divert electron ﬂow
away from NADH production and oxidative metabolism towards
ROS formation. To our knowledge this is the ﬁrst demonstration
that a reduced antioxidant like GSH can work in the opposite di-
rection in mitochondria-amplifying ROS formation instead of
simply quenching it. Our ﬁndings also illustrate the fundamental
complexities surrounding redox signaling and how ROS produc-
tion, antioxidant defense, redox buffering, and oxidative metabo-
lism are heavily integrated into one another [24]. We also found
that Grx2 is able to reverse these effects, deglutathionylating Ogdh
which lowers ROS formation and restores electron ﬂux back tonormal. It is tempting to speculate that glutathione sensing may
have been tempered to ensure that ROS production can be am-
pliﬁed in times when antioxidant capacity is high. This would
ensure the continued use of ROS as a signaling molecule while
simultaneously controlling its production, either through anti-
oxidant systems or via feedback loops that are activated and de-
activated by changes in redox environment.Conﬂict of interest
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